A citation-based method for searching scientific literature

Jennifer B Green, M Angelyn Bethel, Paul W Armstrong, John B Buse, Samuel S Engel, Jyotsna Garg, Robert Josse, Keith D Kaufman, Joerg Koglin, Scott Korn, John M Lachin, Darren K McGuire, Michael J Pencina, Eberhard Standl, Peter P Stein, Shailaja Suryawanshi, Frans Van de Werf, Eric D Peterson, Rury R Holman. N Engl J Med 2015
Times Cited: 1514



Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn, William M Steinberg, Mette Stockner, Bernard Zinman, Richard M Bergenstal, John B Buse. N Engl J Med 2016
Times Cited: 2994




List of shared articles



Times cited

Glycaemic Control and Vascular Complications in Diabetes Mellitus Type 2.
Francesco Maranta, Lorenzo Cianfanelli, Domenico Cianflone. Adv Exp Med Biol 2021
10



Incretin drugs in diabetic kidney disease: biological mechanisms and clinical evidence.
Radica Z Alicic, Emily J Cox, Joshua J Neumiller, Katherine R Tuttle. Nat Rev Nephrol 2021
14

SGLT-2 inhibitors may be targeting higher risk patients with diabetes possibly justifying higher cost: Single center repeated cross-sectional analysis.
Larry A Weinrauch, Jiankang Liu, Alissa R Segal, Jason Woodward, John A D'Elia. J Diabetes Complications 2021
1



Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative.
Jessica M Franklin, Elisabetta Patorno, Rishi J Desai, Robert J Glynn, David Martin, Kenneth Quinto, Ajinkya Pawar, Lily G Bessette, Hemin Lee, Elizabeth M Garry,[...]. Circulation 2021
25

Therapies for the Treatment of Cardiovascular Disease Associated with Type 2 Diabetes and Dyslipidemia.
María Aguilar-Ballester, Gema Hurtado-Genovés, Alida Taberner-Cortés, Andrea Herrero-Cervera, Sergio Martínez-Hervás, Herminia González-Navarro. Int J Mol Sci 2021
3


Glucose-Lowering Medications and Cardiovascular Outcomes.
Madhan Shanmugasundaram, J R Exequiel Pineda, Sangeetha Murugapandian. Curr Cardiol Rep 2021
1

The Safety of Pharmacological and Surgical Treatment of Diabetes in Patients with Diabetic Retinopathy-A Review.
Wojciech Matuszewski, Angelika Baranowska-Jurkun, Magdalena Maria Stefanowicz-Rutkowska, Katarzyna Gontarz-Nowak, Ewa Gątarska, Elżbieta Bandurska-Stankiewicz. J Clin Med 2021
0

Effects of anti-diabetes medications on cardiovascular and kidney outcomes in Asian patients with type 2 diabetes: a rapid evidence assessment and narrative synthesis.
Takashi Kadowaki, Fumiko Yamamoto, Yusuke Taneda, Yusuke Naito, Douglas Clark, Søren S Lund, Tomoo Okamura, Kohei Kaku. Expert Opin Drug Saf 2021
0

The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk.
Cyrielle Caussy, Adrien Aubin, Rohit Loomba. Curr Diab Rep 2021
1

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits-The role of the GLP-1 receptor.
Johanna Helmstädter, Karin Keppeler, Leonie Küster, Thomas Münzel, Andreas Daiber, Sebastian Steven. Br J Pharmacol 2021
1

Report from the CVOT Summit 2020: new cardiovascular and renal outcomes.
Oliver Schnell, Xavier Cos, Francesco Cosentino, Thomas Forst, Francesco Giorgino, Hiddo J L Heersprink, Mikhail Kosiborod, Christoph Wanner, Eberhard Standl. Cardiovasc Diabetol 2021
1

Diabetes Management in Patients with Heart Failure.
Jia Shen, Barry H Greenberg. Diabetes Metab J 2021
0

Diabetic heart disease: A clinical update.
Jake Rajbhandari, Cornelius James Fernandez, Mayuri Agarwal, Beverly Xin Yi Yeap, Joseph M Pappachan. World J Diabetes 2021
2

Cardiovascular Outcome Trials with Glucose-Lowering Drugs.
Tina K Thethi, Anika Bilal, Richard E Pratley. Curr Cardiol Rep 2021
1

Cellular mechanisms and recommended drug-based therapeutic options in diabetic cardiomyopathy.
Lisa Dannenberg, Sarah Weske, Malte Kelm, Bodo Levkau, Amin Polzin. Pharmacol Ther 2021
1

CARDIOVASCULAR EFFECTS OF NON-INSULIN GLUCOSE-LOWERING AGENTS: A COMPREHENSIVE REVIEW OF TRIAL EVIDENCE AND POTENTIAL CARDIOPROTECTIVE MECHANISMS.
Gianluigi Savarese, Javed Butler, Lars H Lund, Deepak L Bhatt, Stefan D Anker. Cardiovasc Res 2021
0

Cardiovascular Outcomes Trials of Incretin-Based Therapies.
Tina K Thethi, Anika Bilal, Richard E Pratley. Diabetes Spectr 2021
0

Role of diabetes in stroke: Recent advances in pathophysiology and clinical management.
Sian A Bradley, Kevin J Spring, Roy G Beran, Dimitrios Chatzis, Murray C Killingsworth, Sonu M M Bhaskar. Diabetes Metab Res Rev 2021
0

JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure.
Hiroyuki Tsutsui, Tomomi Ide, Hiroshi Ito, Yasuki Kihara, Koichiro Kinugawa, Shintaro Kinugawa, Miyuki Makaya, Toyoaki Murohara, Koichi Node, Yoshihiko Saito,[...]. J Card Fail 2021
0

A Review of the Renoprotective Effects of Novel Antidiabetic Agents.
Kelsey M Leite, Allissa M Long, Marissa L Ostroff, Leanna Borges, Gregory Braden. J Pharm Pract 2021
1

Blood Pressure-Lowering Effect of Newer Antihyperglycemic Agents (SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors).
Charalampos I Liakos, Dimitrios P Papadopoulos, Elias A Sanidas, Maria I Markou, Erifili E Hatziagelaki, Charalampos A Grassos, Maria L Velliou, John D Barbetseas. Am J Cardiovasc Drugs 2021
1

The validity of cost-effectiveness analyses of tight glycemic control. A systematic survey of economic evaluations of pharmacological interventions in patients with type 2 diabetes.
Francisco J Barrera, Freddy Jk Toloza, Oscar J Ponce, Jorge A Zuñiga-Hernandez, Larry J Prokop, Nilay D Shah, Gordon Guyatt, Rene Rodriguez-Gutierrez, Victor M Montori. Endocrine 2021
0

Management of patients with chronic heart failure and type 2 diabetes mellitus: the SCODIAC-II study.
Mariarosaria De Luca, Giorgio Bosso, Antonio Valvano, Vincenzo Guardasole, Amodio Botta, Vincenzo Carbone, Giovanni Carella, Andrea Del Buono, Giuseppe Di Giovanni, Biagio Fimiani,[...]. Intern Emerg Med 2021
3

Changing Fields-Diabetes Medications Invading the Cardiovascular Space.
Lauren D Breite, Mackenzie Steck, Brandon Tate Cutshall, Samarth P Shah, Brandon E Cave. Curr Probl Cardiol 2021
0

Optimizing Management of Type 2 Diabetes and Its Complications in Patients With Heart Failure.
Christie A Schumacher, Elizabeth K Van Dril, Kayce M Shealy, Jennifer D Goldman. Clin Diabetes 2021
0

Current Status and Potential Therapeutic Strategies for Using Non-coding RNA to Treat Diabetic Cardiomyopathy.
Amit K Rai, Brooke Lee, Ramesh Gomez, Deepu Rajendran, Mahmood Khan, Venkata Naga Srikanth Garikipati. Front Physiol 2021
1

Prevalence of Cardiovascular and Renal Co-morbidities in Patients with Type 2 Diabetes in the Gulf, a Cross-sectional Observational Study.
Ebaa Al-Ozairi, Mahir K Jallo, Khadija Hafidh, Dalal M Alhajeri, Tarek Ashour, Eissa F N Mahmoud, Zeyad Abd ElAal, Maysoon Loulou. Diabetes Ther 2021
0


Use of diabetes medications in traditional Medicare and Medicare Advantage.
Bruce E Landon, Alan M Zaslavsky, Jeffrey Souza, John Z Ayanian. Am J Manag Care 2021
0

Concurrent diabetes and heart failure: interplay and novel therapeutic approaches.
Qutuba G Karwi, Kim L Ho, Simran Pherwani, Ezra B Ketema, Qiu Yu Sun, Gary D Lopaschuk. Cardiovasc Res 2021
0

Role of newer antidiabetic drugs on cardiovascular prevention and heart failure.
Jesús Miguel Rojas-Velázquez, Alejandro Giralt-Herrera, Jessica Leiva-Enríquez, Jennifer Leiva-Enríquez. Clin Investig Arterioscler 2021
0

Heart failure outcomes and glucagon-like peptide-1 receptor agonists: A systematic review of observational studies.
Omar S Alkhezi, Haifa A Alsuhaibani, Amal A Alhadyab, Mashael E Alfaifi, Basmah Alomrani, Ali Aldossary, Osamah M Alfayez. Prim Care Diabetes 2021
0

Interpretation of clinical trials on the cardiovascular effects of hypoglycemic drugs in people with type2 diabetes.
Ana Romero, Gemma Llauradó, José-Miguel González-Clemente. Endocrinol Diabetes Nutr (Engl Ed) 2021
0

Recent advances in new-onset diabetes mellitus after kidney transplantation.
Tess Montada-Atin, G V Ramesh Prasad. World J Diabetes 2021
0


Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology Community.
Adam J Nelson, Neha J Pagidipati, Vanita R Aroda, Matthew A Cavender, Jennifer B Green, Renato D Lopes, Hussein Al-Khalidi, Tanya Gaynor, Lisa A Kaltenbach, Julienne K Kirk,[...]. Circulation 2021
0

Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China.
Mafalda Ramos, Peng Men, Xu Wang, Anastasia Ustyugova, Mark Lamotte. Cost Eff Resour Alloc 2021
0

Clinical Phenotypes in Patients With Type 2 Diabetes Mellitus: Characteristics, Cardiovascular Outcomes and Treatment Strategies.
Pishoy Gouda, Sijia Zheng, Tricia Peters, Marat Fudim, Varinder Kaur Randhawa, Justin Ezekowitz, Thomas A Mavrakanas, Nadia Giannetti, Michael Tsoukas, Renato Lopes,[...]. Curr Heart Fail Rep 2021
0